Buscar resultados de ensayos clínicos

Patrocinado por

Hemangiosarcoma - 13 Studies Found

Estado Estudiar
Completed Nombre del estudio: A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA
Condición: Advanced Angiosarcoma
Fecha: 2016-11-29
Intervenciones:
  • Biological: TRC105 Other Names
Active, not recruiting Nombre del estudio: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
Condición: Angiosarcoma
Fecha: 2011-02-23
Intervenciones:
  • Drug: Paclitaxel Day 1, 8 and

Completed Nombre del estudio: Evaluation of Votrient in Angiosarcoma
Condición: Angiosarcoma
Fecha: 2014-07-29
Intervenciones: Drug: Pazopanib + Paclitaxel pazopanib in combination with paclitaxel in the treatment of patients with
Active, not recruiting Nombre del estudio: Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma
Condición:
  • Angiosarcomas
  • Soft Tissue Sarcoma

Fecha: 2010-01-21
Intervenciones: Drug: Paclitaxel in combination with Bevacizumab 15 mg/kg, IV
Not yet recruiting Nombre del estudio: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)
Condición: Angiosarcoma
Fecha: 2016-03-29
Intervenciones: Drug: PROPRANOLOL
Completed Nombre del estudio: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
Condición:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Fecha: 2011-10-27
    Intervenciones:
    • Drug: pazopanib hydrochloride

Completed Nombre del estudio: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
Condición:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Fecha: 2012-06-17
    Intervenciones:
    • Other: Laboratory Biomarker Analysis

Recruiting Nombre del estudio: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Condición:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Fecha: 2014-01-22
    Intervenciones: Drug: regorafenib Given PO Other Names:
Recruiting Nombre del estudio: Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
Condición: Sarcoma
Fecha: 2009-04-02
Intervenciones: Drug: sorafenib tosylate
Completed Nombre del estudio: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
Condición: Sarcoma
Fecha: 2005-09-20
Intervenciones: Drug: paclitaxel
Next >>>